These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30238004)

  • 1. EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment.
    Hunter A; Facey K; Thomas V; Haerry D; Warner K; Klingmann I; May M; See W
    Front Med (Lausanne); 2018; 5():231. PubMed ID: 30238004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D.
    Warner K; See W; Haerry D; Klingmann I; Hunter A; May M
    Front Med (Lausanne); 2018; 5():270. PubMed ID: 30356834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials.
    Klingmann I; Heckenberg A; Warner K; Haerry D; Hunter A; May M; See W
    Front Med (Lausanne); 2018; 5():251. PubMed ID: 30246010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes.
    Haerry D; Landgraf C; Warner K; Hunter A; Klingmann I; May M; See W
    Front Med (Lausanne); 2018; 5():230. PubMed ID: 30175100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient advocate perspectives on involvement in HTA: an international snapshot.
    Scott AM; Wale JL;
    Res Involv Engagem; 2017; 3():2. PubMed ID: 29062527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project.
    Sessa C; Schmid C; Tolotti A; Magnin A; Haerry D; Bonetti L; Klingmann I
    Front Med (Lausanne); 2021; 8():795659. PubMed ID: 35004770
    [No Abstract]   [Full Text] [Related]  

  • 8. The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis.
    van Rensen A; Voogdt-Pruis HR; Vroonland E
    Front Med (Lausanne); 2020; 7():558. PubMed ID: 33072776
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient advocacy group involvement in health technology assessments: an observational study.
    Single A; Cabrera A; Fifer S; Tsai J; Paik JY; Hope P
    Res Involv Engagem; 2021 Nov; 7(1):83. PubMed ID: 34823610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing patient perspective in health technology assessment at the local level.
    Gagnon MP; Lepage-Savary D; Gagnon J; St-Pierre M; Simard C; Rhainds M; Lemieux R; Gauvin FP; Desmartis M; Légaré F
    BMC Health Serv Res; 2009 Mar; 9():54. PubMed ID: 19327160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group - Commentary.
    Wale JL; Scott AM; Bertelsen N; Meade N;
    Res Involv Engagem; 2017; 3():3. PubMed ID: 29062528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 14. Stories of Patient Involvement Impact in Health Technology Assessments: A Discussion Paper.
    Single ANV; Facey KM; Livingstone H; Silva AS
    Int J Technol Assess Health Care; 2019; 35(4):266-272. PubMed ID: 31337453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS).
    Serrano-Aguilar P; Asua-Batarrita J; Molina-López MT; Espallargues M; Pons-Rafols J; García-Armesto S; Arriola-Bolado P; López-García M; Faraldo-Vallés MJ; Sánchez-Gómez LM; Juárez-Rojo C; Prieto-Yerro I; Casado-Durández P; Sarria-Santamera A
    Int J Technol Assess Health Care; 2019 Jan; 35(3):176-180. PubMed ID: 31006412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
    Mittermayer R; Huić M; Mestrović J
    Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing patients' and the public's perspectives to health technology assessment: A systematic review of international experiences.
    Gagnon MP; Desmartis M; Lepage-Savary D; Gagnon J; St-Pierre M; Rhainds M; Lemieux R; Gauvin FP; Pollender H; Légaré F
    Int J Technol Assess Health Care; 2011 Jan; 27(1):31-42. PubMed ID: 21262085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.